Both in Pharmaceuticals
Innoviva vs Rapport Therapeutics
Over the past year INVA returned +20.7% and RAPP returned +4.3%; their daily moves had a correlation of 0.21.
INVA +20.7% RAPP +4.3%Growth of $1, one year, split-adjusted
| Metric | INVA | RAPP |
|---|---|---|
| Price | $20.78 | $27.57 |
| Market cap | $1.50B | $1.32B |
| Today | −0.38% | −6.76% |
| 1 month | −1.3% | −34.3% |
| 6 months | −14.3% | −30.6% |
| Year to date | +4.0% | −9.1% |
| 1 year | +19.5% | +6.9% |
| Revenue growth (YoY) | +19.3% | — |
| Gross margin | 81.3% | — |
| Net margin | −69.8% | — |
| P/E (TTM) | 4.2× | — |
| Price / sales | 3.4× | 66.1× |
| Net cash | $319.0M | $436.1M |
| Dividend yield | — | — |
| Volatility (60d) | 22.6% | 59.5% |
| Short % of float | 9.9% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).